The Summer 2026 Prime Therapeutics Report delivers practical insights on the therapies, trends and market developments shaping specialty management today. 

Inside this issue: 

• Autoimmune update: Expanding biosimilar landscape and payer impact 

• IntegratedRx® update: Oncology and cystic fibrosis solutions 

• Managed care newsstand: Policy and industry developments affecting PBM economics, contracting and operations 

• COPD and ophthalmology: Treatment landscape updates and payer management considerations 

• Pipeline: Upcoming decision dates and potential trend drivers 

Whether you’re a managed care executive, clinician or pharmacy leader, this report offers practical insights to help evaluate emerging therapies, prepare for market changes and support informed coverage, access and management decisions. 

Read the report

Subscribe for future issues